These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38892797)

  • 41. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
    Hashash JG; Elkins J; Lewis JD; Binion DG
    Gastroenterology; 2024 Mar; 166(3):521-532. PubMed ID: 38276922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute Myopericarditis with Crohn's Disease Flare-up.
    Kumar M; Tandon V; Mosebach CM; Lopetegui Lia N; Miller W
    Cureus; 2019 Mar; 11(3):e4248. PubMed ID: 31131171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychosocial problems experienced by patients depending on Crohn's disease activity: an exploratory study.
    Otrębski W; Krupa-Nowosad M
    Health Psychol Rep; 2022; 10(2):83-92. PubMed ID: 38084327
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and Efficacy of Inpatient Infliximab Rescue Therapy for Acute Crohn's Disease Flares.
    Whitlock AE; Arndt KR; Zakopoulos I; Wong DJ; Kaul S; Feuerstein J; Crowell KT; Messaris E
    Am Surg; 2024 Jun; 90(6):1591-1598. PubMed ID: 38597300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Wang Y; Tsoulis DJ; MacDonald JK; Feagan BG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003459. PubMed ID: 25099640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of current and former cigarette smoking on the clinical course of Crohn's disease.
    Cosnes J; Carbonnel F; Carrat F; Beaugerie L; Cattan S; Gendre J
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1403-11. PubMed ID: 10571595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized controlled trial of mindfulness-based stress reduction to prevent flare-up in patients with inactive ulcerative colitis.
    Jedel S; Hoffman A; Merriman P; Swanson B; Voigt R; Rajan KB; Shaikh M; Li H; Keshavarzian A
    Digestion; 2014; 89(2):142-55. PubMed ID: 24557009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glutamine for induction of remission in Crohn's disease.
    Akobeng AK; Elawad M; Gordon M
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD007348. PubMed ID: 26853855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries.
    Lichtenstein GR; Yan S; Bala M; Hanauer S
    Am J Gastroenterol; 2004 Jan; 99(1):91-6. PubMed ID: 14687148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding life experiences of people affected by Crohn's disease in Spain. A phenomenological approach.
    García-Sanjuán S; Lillo-Crespo M; Richart-Martínez M; Sanjuán Quiles Á
    Scand J Caring Sci; 2018 Mar; 32(1):354-362. PubMed ID: 28869658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sleep disturbances in Japanese patients with inflammatory bowel disease and their impact on disease flare.
    Uemura R; Fujiwara Y; Iwakura N; Shiba M; Watanabe K; Kamata N; Yamagami H; Tanigawa T; Watanabe T; Tominaga K; Arakawa T
    Springerplus; 2016; 5(1):1792. PubMed ID: 27795934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclosporine for induction of remission in Crohn's disease.
    McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specific Antibiotics Increase the Risk of Flare-Ups in Patients with Inflammatory Bowel Disease: Results from a Danish Nationwide Population-Based Nested Case-Control Study.
    Lo B; Biederman L; Rogler G; Dora B; Kreienbühl A; Vind I; Bendtsen F; Burisch J
    J Crohns Colitis; 2024 Aug; 18(8):1232-1240. PubMed ID: 38367201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic tools for identification of high risk in people with Crohn's disease: systematic review and cost-effectiveness study.
    Edwards SJ; Barton S; Bacelar M; Karner C; Cain P; Wakefield V; Marceniuk G
    Health Technol Assess; 2021 Mar; 25(23):1-138. PubMed ID: 33783345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.
    Liguori G; Lamas B; Richard ML; Brandi G; da Costa G; Hoffmann TW; Di Simone MP; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    J Crohns Colitis; 2016 Mar; 10(3):296-305. PubMed ID: 26574491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Crohn's disease and MRI: assessment of inflammatory activity and tissue damage].
    Cousin F; Louis E; Meunier P
    Rev Med Suisse; 2013 Aug; 9(395):1502-6. PubMed ID: 24024418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natalizumab for induction of remission in Crohn's disease.
    Macdonald JK; McDonald JW
    Cochrane Database Syst Rev; 2006 Jul; (3):CD006097. PubMed ID: 16856112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and characteristics of flare-ups of chronic nonspecific back pain in primary care: a telephone survey.
    Suri P; Saunders KW; Von Korff M
    Clin J Pain; 2012 Sep; 28(7):573-80. PubMed ID: 22699128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohn's disease version.
    Vergara M; Montserrat A; Casellas F; Maudsley M; Gallardo O; Ricart E; Calvet X
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):809-15. PubMed ID: 19404204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.